Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design.

Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design.

Bibliographic Details
Main Authors:	Zachary T Freeman, Andrea L Cox
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-06-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC4928861?pdf=render

Similar Items

The humoral immune response to HCV: understanding is key to vaccine development
by: Siobhán B Cashman, et al.
Published: (2014-11-01)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
by: Florian Wrensch, et al.
Published: (2018-06-01)

From Structural Studies to HCV Vaccine Design
by: Itai Yechezkel, et al.
Published: (2021-05-01)

To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity
by: Felicia Schlotthauer, et al.
Published: (2021-04-01)

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders
by: Romagnoli Luca, et al.
Published: (2010-02-01)

Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
by: Shakti Singh, et al.
Published: (2016-01-01)

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020
by: Jordan J. Feld, et al.
Published: (2021-06-01)

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
by: Pil Soo Sung, et al.
Published: (2015-10-01)

BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny
by: Asimenia Angelidou, et al.
Published: (2020-03-01)

Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
by: Babita Agrawal, et al.
Published: (2019-05-01)

Immunopotentiating and Delivery Systems for HCV Vaccines
by: Alexander K. Andrianov, et al.
Published: (2021-05-01)

Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV
by: Naglaa H. Shoukry
Published: (2021-09-01)

HCV Innate Immune Responses
by: Markus H. Heim
Published: (2009-11-01)

Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design
by: Naomi R. Truong, et al.
Published: (2019-03-01)

Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
by: Samuel T. Pasco, et al.
Published: (2020-09-01)

Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis
by: Maxime W. Lemieux, et al.
Published: (2017-12-01)

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance—Supercontrollers
by: Beatriz Dominguez-Molina, et al.
Published: (2018-12-01)

Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design
by: Vanessa M. Cowton, et al.
Published: (2021-01-01)

A super TLR agonist to improve efficacy of dendritic cell vaccine in induction of anti-HCV immunity.
by: Bangxing Hong, et al.
Published: (2012-01-01)

Legal Immunity? Wrong Diagnosis, Wrong Prescription: Another Lesson from Enterovirus Vaccines
by: Wen-Tsong Chiou
Published: (2009-03-01)

How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations
by: Chatterjee S, et al.
Published: (2006-01-01)

Precision Vaccine Development: Cues From Natural Immunity
by: Barman, S., et al.
Published: (2022)

Transplantation and innate immunity: the lesson of natural killer cells
by: Moretta Lorenzo, et al.
Published: (2009-12-01)

Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.
by: Lauren E Kushner, et al.
Published: (2013-01-01)

Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
by: Almudena Torres-Cornejo, et al.
Published: (2017-04-01)

Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
by: Demetriou Victoria L, et al.
Published: (2010-05-01)

Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine
by: Bikash Sahay, et al.
Published: (2018-05-01)

Engineering synthetic vaccines using cues from natural immunity
by: Swartz, Melody A., et al.
Published: (2014)

Using immunisation caregiver journey interviews to understand and optimise vaccination uptake: lessons from Sierra Leone
by: Dimitri Prybylski, et al.
Published: (2021-05-01)

Vaccine-Induced Cellular Immunity against <i>Bordetella pertussis:</i> Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines
by: Anja Saso, et al.
Published: (2021-08-01)

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
by: Julia L. Casey, et al.
Published: (2019-04-01)

Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection
by: Anne Searls De Groot, et al.
Published: (2014-10-01)

Lessons in AIDS Vaccine Development Learned from Studies of Equine Infectious, Anemia Virus Infection and Immunity
by: Jodi K. Craigo, et al.
Published: (2013-12-01)

Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
by: Atin Khalaj-Hedayati
Published: (2020-01-01)

The effect of influenza vaccine immunization on natural antibodies
by: Živković Irena, et al.
Published: (2021-01-01)

Hepatitis B vaccine efficacy in HCV vertical infected infants
by: Kowalik-Mikolajewska Barbara, et al.
Published: (2008-04-01)

HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development
by: Luisa J. Ströh, et al.
Published: (2020-09-01)

Human Immune Response To Japanese Encephalitis Virus Guides Development Of Vaccines With Long Lasting Immunity
by: Venkatramana, D K
Published: (2013)

Malaria vaccines: lessons from field trials
by: Claudio J. Struchiner, et al.
Published: (1994-07-01)

Malaria vaccines: lessons from field trials
by: Claudio J. Struchiner, et al.
Published: (1994-07-01)